Zydus Cadila has received three product approvals from the US FDA in quick succession. The group has received approvals to market lamotrigine chewable tablets in strengths of 2 mg, 5 mg and 25 mg. lamotrigine tablets -25 mg, 50 mg, 100 mg, 150 mg, 200mg and 250mg and divalproc sprinkle capsules, 125 mg.
The details can be read here.
No comments:
Post a Comment